WeVote
Log In

Bill

Bill

S 92

An Act relative to medical marijuana oversight

194th Legislature (2025-2026) Introduced by Patrick O'Connor

S 92 strengthens Massachusetts medical marijuana program oversight through enhanced regulatory mechanisms and enforcement to improve product safety and prevent illegal market diversion.

Accompanied a study order, see S2817
0
WeVote Research Nonpartisan
Bill Summary · S 92

Legislative bill overview

S 92 proposes to strengthen oversight and regulatory mechanisms for Massachusetts's medical marijuana program. The bill aims to enhance state supervision of cultivation, distribution, testing, and dispensing operations while addressing implementation gaps in existing cannabis regulations.

Why is this important

Medical marijuana oversight directly affects patient access to safe, tested products and determines how effectively the state can prevent diversion to illegal markets. Robust regulatory frameworks protect consumers from contaminated or mislabeled products while ensuring legitimate operators comply with safety standards, which has been a recurring issue in several states' programs.

Potential points of contention

  • Operational costs and compliance burden — Strengthened oversight may increase licensing fees and compliance requirements, potentially affecting smaller operators and patients' access through higher product prices
  • Regulatory scope and authority — Disagreement may arise over which state agency should oversee the program and the extent of their enforcement powers versus local control
  • Patient privacy and data collection — Enhanced tracking systems could raise concerns about medical information security and whether patient participation data might be shared with federal authorities despite state legalization

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.